INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. – FLGT
Pomerantz LLP is investigating claims on behalf of investors ofFulgent Genetics, Inc. (“Fulgent” or the “Company”)(NASDAQ: FLGT).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Fulgentand certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining […]